[go: up one dir, main page]

PE20090652A1 - Compuestos de nicotinamida sustituida y sus usos en medicamentos - Google Patents

Compuestos de nicotinamida sustituida y sus usos en medicamentos

Info

Publication number
PE20090652A1
PE20090652A1 PE2008001619A PE2008001619A PE20090652A1 PE 20090652 A1 PE20090652 A1 PE 20090652A1 PE 2008001619 A PE2008001619 A PE 2008001619A PE 2008001619 A PE2008001619 A PE 2008001619A PE 20090652 A1 PE20090652 A1 PE 20090652A1
Authority
PE
Peru
Prior art keywords
nicotinamide
phenylsulfonil
alkyl
compounds
medicines
Prior art date
Application number
PE2008001619A
Other languages
English (en)
Inventor
Beatrix Merla
Sven Kuhnert
Robert Frank
Dagmar Kaulartz
Wolfgang Schroder
Gregor Bahrenberg
Klaus Schiene
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE20090652A1 publication Critical patent/PE20090652A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE NICOTINAMIDA DE FORMULA (I) DONDE R1 ES ALQUILO(C1-C6), ARILO, HETEROARILO OPCIONALMENTE SUSTITUIDO, ENTRE OTROS; R2 ES H O ALQUILO(C1-C6) OPCIONALMENTE SUSTITUIDO; R3 ES CICLOALQUILO(C3-C10), ARILO, HETEROARILO OPCIONALMENTE SUSTITUIDO, ENTRE OTROS; R4, R5, R6 Y R7 SON CADA UNO H O ALQUILO(C1-C6) OPCIONALMENTE SUSTITUIDO; R8, R9 Y R10 SON CADA UNO H, F, Cl, Br, CF3, ENTRE OTROS; n ES DE 0 A 2; p Y q SON CADA UNO 0 O 1. SON COMPUESTOS PREFERIDOS: 2-(2-(FENILSULFONIL)ETILTIO)-N-(PIRIDIN-2-ILMETIL)NICOTINAMIDA, 2-(2-(FENILSULFONIL)ETILTIO)-N-(PIRIDIN-4-ILMETIL)NICOTINAMIDA, N-METIL-N-(3-METILBENCIL)-2-(2-(FENILSULFONIL)ETILTIO)NICOTINAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON AGONISTAS DE LOS CANALES DE KCNQ2/3 K+ SIENDO UTILES EN EL TRATAMIENTO DEL DOLOR NEUROPATICO, EPILEPSIA, INCONTINENCIA URINARIA
PE2008001619A 2007-09-17 2008-09-17 Compuestos de nicotinamida sustituida y sus usos en medicamentos PE20090652A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007044277A DE102007044277A1 (de) 2007-09-17 2007-09-17 Substituierte Nicotinamid-Verbindungen und deren Verwendung in Arzneimitteln

Publications (1)

Publication Number Publication Date
PE20090652A1 true PE20090652A1 (es) 2009-05-28

Family

ID=40347805

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001619A PE20090652A1 (es) 2007-09-17 2008-09-17 Compuestos de nicotinamida sustituida y sus usos en medicamentos

Country Status (23)

Country Link
US (1) US8084470B2 (es)
EP (1) EP2188258B1 (es)
JP (1) JP5539205B2 (es)
KR (1) KR20100068453A (es)
CN (1) CN101801932A (es)
AR (1) AR068467A1 (es)
BR (1) BRPI0817044A2 (es)
CA (1) CA2699689C (es)
CO (1) CO6260092A2 (es)
CY (1) CY1113551T1 (es)
DE (1) DE102007044277A1 (es)
DK (1) DK2188258T3 (es)
ES (1) ES2400407T3 (es)
HR (1) HRP20130166T1 (es)
IL (1) IL204496A (es)
MX (1) MX2010002506A (es)
NZ (1) NZ583684A (es)
PE (1) PE20090652A1 (es)
PL (1) PL2188258T3 (es)
PT (1) PT2188258E (es)
RU (1) RU2489425C2 (es)
SI (1) SI2188258T1 (es)
WO (1) WO2009036938A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI475020B (zh) * 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
BR112013004562A2 (pt) * 2010-08-27 2016-09-06 Gruenenthal Gmbh 2-óxi-quinolina-3-carboxamidas substituídas como moduladores kcnq2/3
WO2012052167A1 (en) * 2010-10-20 2012-04-26 Grünenthal GmbH Substituted 6-amino-nicotinamides as kcnq2/3 modulators
FR2968661B1 (fr) * 2010-12-14 2016-01-01 Oreal Procede de depigmentation des matieres keratiniques a l'aide de composes thiopyridinones
MX2015004511A (es) * 2012-10-11 2015-07-06 Grünenthal GmbH Tratamiento y/o profilaxis de enfermedades y/o trastornos provocados por tspo.
MX2015006689A (es) 2012-11-28 2015-08-20 Grünenthal GmbH Carboxamidas especificas como moduladores de kcnq2/3.
US9248122B2 (en) 2012-11-28 2016-02-02 Grünenthal GmbH Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
JP7120549B2 (ja) 2016-12-15 2022-08-17 小野薬品工業株式会社 Ｔｒｅｋ（ｔｗｉｋ関連ｋチャネル）チャネルのアクチベータ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022884A (en) * 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
GB9919588D0 (en) * 1999-08-18 1999-10-20 Hoechst Schering Agrevo Gmbh Fungicidal compounds
EP1441722A2 (en) 2001-02-20 2004-08-04 Bristol-Myers Squibb Company Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases
GB0319793D0 (en) * 2003-08-22 2003-09-24 Lilly Co Eli Pyridinylmorpholine derivatives

Also Published As

Publication number Publication date
CN101801932A (zh) 2010-08-11
CY1113551T1 (el) 2016-06-22
US8084470B2 (en) 2011-12-27
AR068467A1 (es) 2009-11-18
DE102007044277A1 (de) 2009-03-19
ES2400407T3 (es) 2013-04-09
KR20100068453A (ko) 2010-06-23
HK1144422A1 (en) 2011-02-18
AU2008300945A1 (en) 2009-03-26
CO6260092A2 (es) 2011-03-22
PL2188258T3 (pl) 2013-04-30
MX2010002506A (es) 2010-03-26
RU2489425C2 (ru) 2013-08-10
IL204496A (en) 2013-02-28
JP5539205B2 (ja) 2014-07-02
SI2188258T1 (sl) 2013-01-31
RU2010115184A (ru) 2011-10-27
WO2009036938A1 (de) 2009-03-26
CA2699689A1 (en) 2009-03-26
HRP20130166T1 (hr) 2013-03-31
PT2188258E (pt) 2013-01-23
BRPI0817044A2 (pt) 2015-03-24
DK2188258T3 (da) 2013-01-14
EP2188258B1 (de) 2012-11-28
US20090076086A1 (en) 2009-03-19
EP2188258A1 (de) 2010-05-26
NZ583684A (en) 2011-04-29
CA2699689C (en) 2015-03-24
JP2010539124A (ja) 2010-12-16

Similar Documents

Publication Publication Date Title
PE20090652A1 (es) Compuestos de nicotinamida sustituida y sus usos en medicamentos
PE20120780A1 (es) Nicotinamida sustituida como moduladores kcnq2/3
PE20120790A1 (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3
PE20110285A1 (es) Derivados de sulfonamidofenil propionamida como ligandos del receptor vaniloide del subtipo 1
PE20090435A1 (es) Inhibidores de tetrahidropiranocromeno de gamma secretasa
PE20200935A1 (es) Compuestos derivados de 2-((bifenil)pirrolidin o piperidin) sulfonamida o carboxamida agonistas de receptores de orexina 2
MX390793B (es) Amidas de piridona deuteradas y sus profármacos como moduladores de los canales de sodio.
PE20060241A1 (es) 2-quinolil-oxazoles sustituidos como inhibidores de pde4
AR077935A1 (es) Derivados de 3-amino-5 fenil-5,6-dihidro-2h-(1,4)oxazina
PE20170004A1 (es) Inhibidores de biaril cinasa
PE20071245A1 (es) COMPUESTOS INDOL SULFONAMIDA COMO MODULADORES DEL RECEPTOR DE PROGESTERONA SELECTIVOS (SPRMs)
PE20121058A1 (es) Compuestos que modulan el receptor de androgenos
PE20141375A1 (es) Activadores de glucoquinasa
PE20140011A1 (es) Compuestos y composiciones novedosos para la inhibicion de nampt
PE20091005A1 (es) N-(2-(hetaril)aril)arilsulfonamidas y n-(2-(hetaril)hetaril)arilsulfonamidas
AR070828A1 (es) Derivados de azetidina y ciclobutano como inhibidores de jak
PE20091974A1 (es) Derivados de indazoles sustituidos con fenil o piridinilo
PE20061124A1 (es) Compuestos y derivados de dibencil amina
PE20061353A1 (es) Compuestos de sulfonamida-tiazolopiridina como activadores de glucocinasa
PE20080409A1 (es) Compuestos que modulan en el receptor cb2
PE20121509A1 (es) Compuestos de triazolopiridinas como inhibidores de quinasa mps-1
PE20110063A1 (es) DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK
PE20191557A1 (es) Compuestos de pirimidinil-pyridiloxi-naftil y metodos para tratar enfermedades y trastornos relacionados con ire1
PE20110384A1 (es) Derivados de carbamatos de alquiltiazoles y su preparacion
PE20091102A1 (es) Moduladores imidazolo-, oxazolo-, y tiazolopirimidina del trpv1

Legal Events

Date Code Title Description
FC Refusal